Immunotherapy moves into the breast cancer landscape
The Journal of Community and Supportive Oncology. 2015 January;13(1):30-33 | 10.12788/jcso.0104
January 16, 2015|The Journal of Community and Supportive Oncology
At this year’s San Antonio Breast Cancer Symposium, investigators presented some encouraging findings for difficult-to-treat patient populations, but issues such as therapy side effects and fertility concerns in younger patients also highlighted the importance of looking closely at the risk-benefit relationship in delivering quality, personalized care to patients with breast cancer.
Click on the PDF icon at the top of this introduction to read the full article.
